Catalog No.S1840 Synonyms: nsc79037

Lomustine  Chemical Structure

Molecular Weight(MW): 233.7

Lomustine inhibits cancer cells by damaging the DNA and stops cells from dividing.

Size Price Stock Quantity  
USD 67 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

1 Customer Review

  • Initial range finding concentration response analysis of the cytotoxic effects of (A) lomustine (IC50 = 12 μM) and (B) vincristine (IC50 = 1.5 nM) on D283 Med in a clonogenic assay of cell survival

    J Cell Mol Med, 2017, 21(12):3337-3346. Lomustine purchased from Selleck.

Purity & Quality Control

Choose Selective DNA/RNA Synthesis Inhibitors

Biological Activity

Description Lomustine inhibits cancer cells by damaging the DNA and stops cells from dividing.
Features A more specific and potent anti-medulloblastoma agent compared to Vincristine.
In vitro

Lomustine inhibits the growth of ZR-75-1 and U373 with IC50 of 12 μM and 15 μM, respectively. Lomustine reduces the level of expression of the DNA repair protein O6-alkylguanine-DNA alkyltransferase. [1] Lomustine (420 μM) triggers apoptosis through the mitochondrial pathway via decrease in the level of the anti-apoptosis proteins Bcl-2 and Bcl-xl, respectively, in both medulloblastoma and normal human epithelial and fibroblast cells. Lomustine induces cell cycle delay in G2/M phase in medulloblastoma cells and up-regulates p21 protein level in a p53-independent manner in HFSN1 cells. [2]

In vivo Lomustine can cause delayed, cumulative dose-related, chronic hepatotoxicity that is irreversible and can be fatal. [4] Lomustine could result in infrequent severe hematological toxicity in cats with spontaneously arising tumors, and the incidence of either grade III or IV neutropenia and thrombocytopenia is 4.1% and 1.0%, respectively. Lomustine trends toward a greater likelihood for progressive neutropenia and statistically significant higher response rates in cats with spontaneously arising tumors. [5]


Cell Research:[1]
+ Expand
  • Cell lines: XP cells
  • Concentrations: 133 μM
  • Incubation Time: 1 hour
  • Method: Cell lines are routinely grown as monolayers in DMEM supplemented with 10% foetal calf serum, 25 mm HEPES, glutamine and penicillin/streptomycin. Cytotoxicity studies are carried out in HEPES-free medium in a 5% CO2 atmosphere. 750-1000 cells/well are plated in 96 well plates and after overnight incubation are treated for 2 hours with or without 33 μM BG. Temozolomide or CCNU is then added for 1 hour in the same medium, the final DMSO concentration not exceeding 1%. The cells are grown for a further 7 days in fresh medium and assayed for protein content by the NCI sulphorhodamine assay; growth studies show that cells are in log phase growth during the assay period. For the repeat temozolomide dosing schedule cells are given consecutive 24 hours treatments, with fresh medium each day. Assays are carried out at least in duplicate.
    (Only for Reference)
Animal Research:[3]
+ Expand
  • Animal Models: Dogs
  • Formulation: Saline
  • Dosages: 90 mg/m2
  • Administration: Orally
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 46 mg/mL (196.83 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
30% propylene glycol, 5% Tween 80, 65% D5W, pH 4
For best results, use promptly after mixing.
10 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 233.7


CAS No. 13010-47-4
Storage powder
in solvent
Synonyms nsc79037

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03022578 Recruiting Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System|Glioblastoma|Anaplastic Astrocytoma M.D. Anderson Cancer Center|Monteris Medical November 7 2017 Phase 2
NCT03025893 Recruiting Glioblastoma Multiforme|Glioblastoma Adult|Glioblastoma|Recurrent Brain Tumor|GBM VU University Medical Center August 31 2018 Phase 2|Phase 3
NCT01934361 Completed Recurrent Glioblastoma Multiforme Novartis Pharmaceuticals|Novartis February 28 2014 Phase 1
NCT03149575 Active not recruiting Glioblastoma Multiforme|Glioblastoma|Glioma|GBM|Brain Cancer DelMar Pharmaceuticals Inc. October 27 2017 Phase 3
NCT02796261 Recruiting Anaplastic Astrocytoma|Recurrent Anaplastic Astrocytoma Orbus Therapeutics Inc. July 2016 Phase 3
NCT02765165 Active not recruiting Solid Tumors (Phase 1)|Relapsed/Recurrent GBM (Phase 2) Proximagen LLC April 2016 Phase 1|Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

DNA/RNA Synthesis Signaling Pathway Map

Related DNA/RNA Synthesis Products

Tags: buy Lomustine | Lomustine ic50 | Lomustine price | Lomustine cost | Lomustine solubility dmso | Lomustine purchase | Lomustine manufacturer | Lomustine research buy | Lomustine order | Lomustine mouse | Lomustine chemical structure | Lomustine mw | Lomustine molecular weight | Lomustine datasheet | Lomustine supplier | Lomustine in vitro | Lomustine cell line | Lomustine concentration | Lomustine nmr
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID